肌紅蛋白的全球市場(2022年～2026年)

Global Myoglobin Market 2022-2026

出版日期: 2022年07月26日 | 出版商:

TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球肌紅蛋白的市場規模在2022年～2026年的預測期間預計將以4.1％的年複合成長率擴大，成長到9,920萬美元。市場成長的主要因素有使用肌紅蛋白作為診斷 ACS 和肌肉損傷的生物標誌物，診斷實驗室對肌紅蛋白試劑的需求增加，以及肌紅蛋白抗體在免疫印跡、ELISA 和其他酶分析的適用性而需求增加等。

本報告提供肌紅蛋白的世界市場調查，提供市場規模和預測，市場促進因素及課題，市場趨勢，各地區的市場分析，業者情勢，主要供應商分析等系統性資訊。

Technavio has been monitoring the myoglobin market and it is poised to grow by $ 99.2 mn during 2022-2026, accelerating at a CAGR of 4.1% during the forecast period. Our report on the myoglobin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the usage of myoglobin as a biomarker for the diagnosis of ACS and muscle injuries, rising demand for myoglobin reagents from diagnostic laboratories, and the suitability of myoglobin antibodies for immunoblotting, ELISA, and other enzymatic assays.

The myoglobin market analysis includes type segment and geographic landscape.

Technavio's myoglobin market is segmented as below:

By Type

Animal myoglobin
Human myoglobin

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the demand for myoglobin instruments for emergency diagnostic patient management as one of the prime reasons driving the myoglobin market growth during the next few years. Also, growing research studies on biomarkers in cardiology and the launch of new myoglobin products to improve diagnostic testing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the myoglobin market covers the following areas:

Myoglobin market sizing
Myoglobin market forecast
Myoglobin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myoglobin market vendors that include Abbott Laboratories, BBI Solutions, Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Danaher Corp., DiaSys Diagnostic Systems GmbH, F. Hoffmann La Roche Ltd., General Atomics, HORIBA Ltd., Merck KGaA, OriGene Technologies Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Randox Laboratories Ltd., Scripps Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corp. Also, the myoglobin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Animal myoglobin - Market size and forecast 2021-2026
Exhibit 28: Chart on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Animal myoglobin - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Animal myoglobin - Year-over-year growth 2021-2026 (%)
5.4 Human myoglobin - Market size and forecast 2021-2026
Exhibit 32: Chart on Human myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Human myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Human myoglobin - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Human myoglobin - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 85: Abbott Laboratories - Overview
Exhibit 86: Abbott Laboratories - Business segments
Exhibit 87: Abbott Laboratories - Key news
Exhibit 88: Abbott Laboratories - Key offerings
Exhibit 89: Abbott Laboratories - Segment focus
10.4 Bio Rad Laboratories Inc.
Exhibit 90: Bio Rad Laboratories Inc. - Overview
Exhibit 91: Bio Rad Laboratories Inc. - Business segments
Exhibit 92: Bio Rad Laboratories Inc. - Key news
Exhibit 93: Bio Rad Laboratories Inc. - Key offerings
Exhibit 94: Bio Rad Laboratories Inc. - Segment focus
10.5 F. Hoffmann La Roche Ltd.
Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
10.6 Merck KGaA
Exhibit 100: Merck KGaA - Overview
Exhibit 101: Merck KGaA - Business segments
Exhibit 102: Merck KGaA - Key news
Exhibit 103: Merck KGaA - Key offerings
Exhibit 104: Merck KGaA - Segment focus
10.7 OriGene Technologies Inc.
Exhibit 105: OriGene Technologies Inc. - Overview
Exhibit 106: OriGene Technologies Inc. - Product / Service
Exhibit 107: OriGene Technologies Inc. - Key offerings
10.8 PerkinElmer Inc.
Exhibit 108: PerkinElmer Inc. - Overview
Exhibit 109: PerkinElmer Inc. - Business segments
Exhibit 110: PerkinElmer Inc. - Key news
Exhibit 111: PerkinElmer Inc. - Key offerings
Exhibit 112: PerkinElmer Inc. - Segment focus
10.9 Randox Laboratories Ltd.
Exhibit 113: Randox Laboratories Ltd. - Overview
Exhibit 114: Randox Laboratories Ltd. - Product / Service
Exhibit 115: Randox Laboratories Ltd. - Key offerings
10.10 Scripps Laboratories Inc.
Exhibit 116: Scripps Laboratories Inc. - Overview
Exhibit 117: Scripps Laboratories Inc. - Product / Service
Exhibit 118: Scripps Laboratories Inc. - Key offerings
10.11 Thermo Fisher Scientific Inc.
Exhibit 119: Thermo Fisher Scientific Inc. - Overview
Exhibit 120: Thermo Fisher Scientific Inc. - Business segments
Exhibit 121: Thermo Fisher Scientific Inc. - Key news
Exhibit 122: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 123: Thermo Fisher Scientific Inc. - Segment focus
10.12 Tosoh Corp.
Exhibit 124: Tosoh Corp. - Overview
Exhibit 125: Tosoh Corp. - Business segments
Exhibit 126: Tosoh Corp. - Key offerings
Exhibit 127: Tosoh Corp. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations
- investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Animal myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Animal myoglobin - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Animal myoglobin - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Human myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Human myoglobin - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Human myoglobin - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Human myoglobin - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Abbott Laboratories - Overview
Exhibits86: Abbott Laboratories - Business segments
Exhibits87: Abbott Laboratories - Key news
Exhibits88: Abbott Laboratories - Key offerings
Exhibits89: Abbott Laboratories - Segment focus
Exhibits90: Bio Rad Laboratories Inc. - Overview
Exhibits91: Bio Rad Laboratories Inc. - Business segments
Exhibits92: Bio Rad Laboratories Inc. - Key news
Exhibits93: Bio Rad Laboratories Inc. - Key offerings
Exhibits94: Bio Rad Laboratories Inc. - Segment focus
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: Merck KGaA - Overview
Exhibits101: Merck KGaA - Business segments
Exhibits102: Merck KGaA - Key news
Exhibits103: Merck KGaA - Key offerings
Exhibits104: Merck KGaA - Segment focus
Exhibits105: OriGene Technologies Inc. - Overview
Exhibits106: OriGene Technologies Inc. - Product / Service
Exhibits107: OriGene Technologies Inc. - Key offerings
Exhibits108: PerkinElmer Inc. - Overview
Exhibits109: PerkinElmer Inc. - Business segments
Exhibits110: PerkinElmer Inc. - Key news
Exhibits111: PerkinElmer Inc. - Key offerings
Exhibits112: PerkinElmer Inc. - Segment focus
Exhibits113: Randox Laboratories Ltd. - Overview
Exhibits114: Randox Laboratories Ltd. - Product / Service
Exhibits115: Randox Laboratories Ltd. - Key offerings
Exhibits116: Scripps Laboratories Inc. - Overview
Exhibits117: Scripps Laboratories Inc. - Product / Service
Exhibits118: Scripps Laboratories Inc. - Key offerings
Exhibits119: Thermo Fisher Scientific Inc. - Overview
Exhibits120: Thermo Fisher Scientific Inc. - Business segments
Exhibits121: Thermo Fisher Scientific Inc. - Key news
Exhibits122: Thermo Fisher Scientific Inc. - Key offerings
Exhibits123: Thermo Fisher Scientific Inc. - Segment focus
Exhibits124: Tosoh Corp. - Overview
Exhibits125: Tosoh Corp. - Business segments
Exhibits126: Tosoh Corp. - Key offerings
Exhibits127: Tosoh Corp. - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations